Overview
Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With Schizophrenia
Status:
Completed
Completed
Trial end date:
2016-12-01
2016-12-01
Target enrollment:
Participant gender: